Venetoclax and Decitabine in R/R T-ALL

NCT06712121 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

T Lymphoblastic Leukemia/Lymphoma

Interventions

DRUG: decitabine plus venetoclax

Sponsor

Seoul National University Hospital

Collaborators

[object Object]